- Home
- LGVN vs NXGL Comparison
LGVN vs NXGL Comparison
Compare LGVN & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- NXGL
- Stock Information
- Founded
- LGVN 2014
- NXGL 1997
- Country
- LGVN United States
- NXGL United States
- Employees
- LGVN N/A
- NXGL N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- NXGL Medical/Dental Instruments
- Sector
- LGVN Health Care
- NXGL Health Care
- Exchange
- LGVN Nasdaq
- NXGL Nasdaq
- Market Cap
- LGVN 23.4M
- NXGL 19.4M
- IPO Year
- LGVN 2021
- NXGL 2021
- Fundamental
- Price
- LGVN $1.24
- NXGL $2.17
- Analyst Decision
- LGVN Strong Buy
- NXGL
- Analyst Count
- LGVN 3
- NXGL 0
- Target Price
- LGVN $8.67
- NXGL N/A
- AVG Volume (30 Days)
- LGVN 123.3K
- NXGL 41.1K
- Earning Date
- LGVN 05-08-2025
- NXGL 05-13-2025
- Dividend Yield
- LGVN N/A
- NXGL N/A
- EPS Growth
- LGVN N/A
- NXGL N/A
- EPS
- LGVN N/A
- NXGL N/A
- Revenue
- LGVN $2,225,000.00
- NXGL $10,228,000.00
- Revenue This Year
- LGVN N/A
- NXGL $52.35
- Revenue Next Year
- LGVN $17.49
- NXGL $42.38
- P/E Ratio
- LGVN N/A
- NXGL N/A
- Revenue Growth
- LGVN 127.50
- NXGL 116.01
- 52 Week Low
- LGVN $0.77
- NXGL $1.84
- 52 Week High
- LGVN $6.40
- NXGL $5.10
- Technical
- Relative Strength Index (RSI)
- LGVN 37.16
- NXGL 35.51
- Support Level
- LGVN $1.25
- NXGL $2.10
- Resistance Level
- LGVN $1.37
- NXGL $2.27
- Average True Range (ATR)
- LGVN 0.09
- NXGL 0.23
- MACD
- LGVN -0.01
- NXGL -0.02
- Stochastic Oscillator
- LGVN 1.75
- NXGL 8.06
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.